Improvement of Overall Survival using TKIs as Salvage Therapy in Advanced Thyroid Carcinoma: Real-Life Data on a Single Center Experience
<i>Background:</i> Tyrosine kinase inhibitors (TKIs) have improved progression-free survival in patients with advanced thyroid cancer. So far, few studies have investigated the efficacy of TKIs in a second-line setting. The purpose of our study was to explore the salvage therapy efficacy...
Main Authors: | Lucia Brilli, Cristina Dalmiglio, Tania Pilli, Filomena Barbato, Fabio Maino, Marco Capezzone, Alessandra Cartocci, Maria Grazia Castagna |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/3/384 |
Similar Items
-
Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
by: Priyanka C. Iyer, et al.
Published: (2018-07-01) -
The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology
by: Marco Capezzone, et al.
Published: (2021-02-01) -
Kinase Inhibitors in the Treatment of Thyroid Cancer: Institutional Experience
by: Matea Pešorda, et al.
Published: (2020-01-01) -
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
by: Massimo Santoro, et al.
Published: (2020-04-01) -
Treatment of Unresectable Differentiated Thyroid Carcinoma With Upfront External Radiotherapy and Salvage Surgery: A STROBE-Compliant Retrospective Cohort Study
by: José F. Carrillo, et al.
Published: (2021-01-01)